• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 26
      Impact of Clinical Guidelines on PSMA-PET Implementation "Presentation" - Emmanuel Antonarakis - 19 day(s) ago

      At the 2025 UCSF-UCLA PSMA Conference, EmmanuelAntonarakis reviews US guidelines for PSMA-PET in prostate cancer from NCCN, SNMMI, and AUA/SUO. He notes consensus on use for biochemical recurrence and Pluvicto eligibility, with NCCN no longer requiring conventional imaging first. He identifies guideline gaps regarding quantification and response assessment, highlighting upcoming PCWG4 and SPARC…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        What is the impact of clinical guidelines on PSMA-PET implementation? Presentation by @EAntonarakis @UMNCancer breaking down NCCN, SNMMI, and AUA/SUO recommendations, highlighting areas for improvement and upcoming initiatives. #WatchNow > https://t.co/eH2zBZG5Sw @NCCN @SNM_MI https://t.co/KxOMtSWDeK

    • Mashup Score: 8
      Pelvic Muscle Rehabilitation after Radical Prostatectomy - Diane Newman - 2 month(s) ago

      Diane Newman delivers a presentation on pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. She explained that while incontinence initially affects 2-90% of patients, most improve within 2-3 months, though 5-20% may experience ongoing symptoms beyond two years. Newman emphasized the importance of pre-…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Pelvic muscle rehabilitation after radical prostatectomy. @DrDianeNewman discusses pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. #WatchNow on UroToday > https://t.co/4w1elr4CJM https://t.co/9e9jWhtp4A

    • Mashup Score: 8
      Expanding Horizons: Targets and Isotopes in Cancer Theranostics - Martin Pomper - 4 month(s) ago

      Oliver Sartor interviews Martin Pomper about radiopharmaceuticals and theranostics in cancer treatment. Dr. Pomper discusses his long-standing interest in the field, highlighting the advantages of small molecule radiopharmaceuticals over antibodies and other biological agents. He explains his focus on Astatine-211 as a promising alpha emitter for targeted therapy, citing its single alpha decay…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Expanding Horizons: targets and isotopes in cancer theranostics. @radnucmp @UTSWMedCenter joins Oliver Sartor, MD @MayoClinic in this discussion on radiopharmaceuticals and theranostics in cancer treatment. #WatchNow on UroToday > https://t.co/yGCkwMXx0w https://t.co/ASXUd1xRpv

    • Mashup Score: 10
      Transperineal vs Transrectal Prostate Biopsy: Clinical Trial Findings - Badar Mian - 4 month(s) ago

      Badar Mian discusses randomized clinical trials comparing transperineal (TP) and transrectal (TR) prostate biopsy approaches. Despite previous beliefs favoring TP biopsies for lower infection rates and better cancer detection, three major trials (ProBE-PC, PREVENT, and PERFECT) show no significant differences in sepsis rates or cancer detection between the two methods. The studies reveal similar…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Transperineal vs transrectal prostate biopsy: Clinical trial findings. @BadarMian1 joins @EDavidCrawford to discuss. This research challenges the trend toward favoring TP biopsies and suggests a need for further evaluation of both approaches. #WatchNow > https://t.co/76Ic4GAfGl https://t.co/E3UGbXsmtv

    • Mashup Score: 4
      Impact of ACA on Gender-Affirming Care: Urology Study Insights - Akanksha Mehta & Eric Walton - 4 month(s) ago

      Ruchika Talwar interviews Eric Walton and Akanksha Metha about their study on the impact of legislation on access to gender-affirming care, published in the Gold Journal. The research examines the effects of the Affordable Care Act on insurance coverage for transgender and gender-diverse adults using the MarketScan Commercial Claims database from 2009 to 2022. The study reveals a significant…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Impact of the Affordable Care Act on gender-affirming care: Urology study insights. @akankshamehtamd and @ercwltn joins @RuchikaTalwarMD to discuss their work on the impact of legislation on access to gender-affirming care. #WatchNow on UroToday > https://t.co/EtcCyPn0Hb https://t.co/AWInna04Xs

    • Mashup Score: 8
      Pelvic Muscle Rehabilitation after Radical Prostatectomy - Diane Newman - 4 month(s) ago

      Diane Newman delivers a presentation on pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. She explained that while incontinence initially affects 2-90% of patients, most improve within 2-3 months, though 5-20% may experience ongoing symptoms beyond two years. Newman emphasized the importance of pre-…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Pelvic muscle rehabilitation after radical prostatectomy. @DrDianeNewman discusses pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. #WatchNow on UroToday > https://t.co/4w1elr4CJM https://t.co/9e9jWhtp4A

    • Mashup Score: 8
      Expanding Horizons: Targets and Isotopes in Cancer Theranostics - Martin Pomper - 5 month(s) ago

      Oliver Sartor interviews Martin Pomper about radiopharmaceuticals and theranostics in cancer treatment. Dr. Pomper discusses his long-standing interest in the field, highlighting the advantages of small molecule radiopharmaceuticals over antibodies and other biological agents. He explains his focus on Astatine-211 as a promising alpha emitter for targeted therapy, citing its single alpha decay…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Expanding Horizons: targets and isotopes in cancer theranostics. @radnucmp @UTSWMedCenter joins Oliver Sartor, MD @MayoClinic in this discussion on radiopharmaceuticals and theranostics in cancer treatment. #WatchNow on UroToday > https://t.co/yGCkwMXx0w https://t.co/ASXUd1xRpv

    • Mashup Score: 5
      Transperineal vs Transrectal Prostate Biopsy: Trial Findings and Discussion - Badar Mian - 5 month(s) ago

      In this follow-up discussion, Badar Mian and E David Crawford delve deeper into the implications of clinical trials comparing transperineal (TP) and transrectal (TR) prostate biopsies. They address key issues such as antibiotic use, patient comfort, and sampling accuracy. Dr. Mian notes that many European centers still use antibiotics for TP biopsies, contrary to claims of antibiotic avoidance….

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Transperineal vs transrectal prostate biopsy: Trial findings and discussion. @BadarMian1 @AlbanyMed joins @EDavidCrawford @UCSanDiego to discuss the implications of clinical trials comparing transperineal and transrectal prostate biopsies. #WatchNow > https://t.co/d4kXrikD1D https://t.co/ZFR8BDeQ0W

    • Mashup Score: 9
      Transperineal vs Transrectal Prostate Biopsy: Clinical Trial Findings - Badar Mian - 5 month(s) ago

      Badar Mian discusses randomized clinical trials comparing transperineal (TP) and transrectal (TR) prostate biopsy approaches. Despite previous beliefs favoring TP biopsies for lower infection rates and better cancer detection, three major trials (ProBE-PC, PREVENT, and PERFECT) show no significant differences in sepsis rates or cancer detection between the two methods. The studies reveal similar…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        Transperineal vs transrectal prostate biopsy: Clinical trial findings. @BadarMian1 joins @EDavidCrawford to discuss. This research challenges the trend toward favoring TP biopsies and suggests a need for further evaluation of both approaches. #WatchNow > https://t.co/76Ic4GAfGl https://t.co/E3UGbXsmtv

    • Mashup Score: 4
      Nadofaragene Firadenovec: Adding to the Treatment Regimen Protocol - Joshua Meeks - 5 month(s) ago

      Sam Chang engages with Josh Meeks to discuss nadofaragene firadenovec’s role in treating BCG-unresponsive bladder cancer. They consider the significance of clinical trials and FDA approval for nadofaragene, noting patient interest in new treatment options. Dr. Meeks outlines the challenges with current therapies, including dual chemotherapy and Pembrolizumab, and points to nadofaragene’s…

      Source: www.urotoday.com
      Categories: General Medicine News, General News
      Tweet Tweets with this article
      • Profile photo of 	urotoday
        urotoday

        An exciting discussion! @UroCancerMD and @JoshMeeks dive into the role of nadofaragene firadenovec in treating BCG-unresponsive bladder cancer, exploring its efficacy, quarterly dosing, and more. #WatchNow for valuable insights > https://t.co/99iIinkYjU @ferring https://t.co/nWjdL7YKWD

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings